• English
    • español
    • português (Brasil)
  • English 
    • English
    • español
    • português (Brasil)
  • Login
View Item 
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • View Item
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Non-severe vs severe symptomatic COVID-19: 104 cases from the outbreak on the cruise ship “Diamond Princess” in Japan

 
Thumbnail
Date
2020-03-20
Author
Sakiko Tabata et. al.
Metadata
Show full item record
Abstract
Background: The ongoing outbreak of 2019 novel coronavirus disease (COVID-19) is a global threat. Clarifying its clinical features such as risk factors for disease progression is a pressing issue. We analyzed the difference between non-severe and severe cases with COVID-19 as a result of the mass infection on a cruise ship “Diamond Princess” in Japan. Methods In this retrospective, single-center study, total 104 cases of laboratory-confirmed COVID-19 were enrolled from the mass infection on the cruise ship from 11th to 25th Feb, 2020, at Self-Defense Forces Central Hospital in Japan. Clinical records, laboratory data, and radiological findings were collected and analyzed. Clinical outcomes were followed up until 26th Feb, 2020. Findings Of the 104 patients, 47 were male. The median age was 68 years. During the observation period, eight patients deteriorated into the severe cases. Finally, 76 and 28 patients were classified as non-severe (asymptomatic, mild), and severe cases, respectively. Chest CT abnormalities were found in 43 in non-severe cases and 23 in severe cases. The prevalence of consolidation on chest CT scan and lymphopenia on the admission day was significantly higher in severe cases and in the eight cases which worsened into severe disease during the observation period. Interpretation The high proportion of non-severe cases corrects the assessment of the trend of the outbreak. Consolidation on chest CT scan and lymphopenia were possible risk factors for deterioration of COVID-19 and contribute to the clinical management. Funding Not applicable.
URI
https://doi.org/10.1101/2020.03.18.20038125
Collections
  • Technical documents and research evidence on COVID-19

Browse

AllCommunities & CollectionsBy Issue DateAuthorsTitlesCategorySubjectsThis CollectionBy Issue DateAuthorsTitlesCategorySubjects

My Account

LoginRegister

Pan American Health Organization
World Health Organization. Regional Office for the Americas
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America

Content Disclaimer (Important notes about the material)

Links

  • WHO International Clinical Trial Registry Platform (ICTRP)
  • WHO Coronavirus disease R&D Blueprint
  • WHO Database of Publications on Coronavirus Disease
  • PAHO Coronavirus Disease
  • PAHO/BIREME Windows of Knowledge COVID-19
  • Evidence aid Coronavirus (COVID-19) resources

  • PAHO Digital Library (IRIS PAHO)
  • Virtual Health Library (VHL)
  • Global Index Medicus (GIM)